Cargando…

Broad-Spectrum Antiviral Activity of Influenza A Defective Interfering Particles against Respiratory Syncytial, Yellow Fever, and Zika Virus Replication In Vitro

New broadly acting and readily available antiviral agents are needed to combat existing and emerging viruses. Defective interfering particles (DIPs) of influenza A virus (IAV) are regarded as promising options for the prevention and treatment of IAV infections. Interestingly, IAV DIPs also inhibit u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pelz, Lars, Piagnani, Elena, Marsall, Patrick, Wynserski, Nancy, Hein, Marc Dominique, Marichal-Gallardo, Pavel, Kupke, Sascha Young, Reichl, Udo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537524/ https://www.ncbi.nlm.nih.gov/pubmed/37766278 http://dx.doi.org/10.3390/v15091872

Ejemplares similares

Multiscale model of defective interfering particle replication for influenza A virus infection in animal cell culture
por: Rüdiger, Daniel, et al.
Publicado: (2021)

Antiviral Activity of Influenza A Virus Defective Interfering Particles against SARS-CoV-2 Replication In Vitro through Stimulation of Innate Immunity
por: Rand, Ulfert, et al.
Publicado: (2021)

OP7, a novel influenza A virus defective interfering particle: production, purification, and animal experiments demonstrating antiviral potential
por: Hein, Marc D., et al.
Publicado: (2020)

Generation of “OP7 chimera” defective interfering influenza A particle preparations free of infectious virus that show antiviral efficacy in mice
por: Dogra, Tanya, et al.
Publicado: (2023)

Cell culture-based production and in vivo characterization of purely clonal defective interfering influenza virus particles
por: Hein, Marc D., et al.
Publicado: (2021)

Semi-continuous Propagation of Influenza A Virus and Its Defective Interfering Particles: Analyzing the Dynamic Competition To Select Candidates for Antiviral Therapy
por: Pelz, Lars, et al.
Publicado: (2021)

Defective Interfering Particles with Broad-Acting Antiviral Activity for Dengue, Zika, Yellow Fever, Respiratory Syncytial and SARS-CoV-2 Virus Infection
por: Lin, Min-Hsuan, et al.
Publicado: (2022)

Cell culture–based production of defective interfering influenza A virus particles in perfusion mode using an alternating tangential flow filtration system
por: Hein, Marc D., et al.
Publicado: (2021)

A Novel Type of Influenza A Virus-Derived Defective Interfering Particle with Nucleotide Substitutions in Its Genome
por: Kupke, Sascha Young, et al.
Publicado: (2019)

Single-Cell Analysis Uncovers a Vast Diversity in Intracellular Viral Defective Interfering RNA Content Affecting the Large Cell-to-Cell Heterogeneity in Influenza A Virus Replication
por: Kupke, Sascha Young, et al.
Publicado: (2020)

Cell culture-based production of defective interfering particles for influenza antiviral therapy
por: Wasik, Milena A., et al.
Publicado: (2017)

Multiscale modeling of influenza A virus replication in cell cultures predicts infection dynamics for highly different infection conditions
por: Rüdiger, Daniel, et al.
Publicado: (2019)

Influenza virus intracellular replication dynamics, release kinetics, and particle morphology during propagation in MDCK cells
por: Frensing, Timo, et al.
Publicado: (2016)

Process intensification of EB66® cell cultivations leads to high-yield yellow fever and Zika virus production
por: Nikolay, Alexander, et al.
Publicado: (2018)

The Antiviral Small-Interfering RNA Pathway Induces Zika Virus Resistance in Transgenic Aedes aegypti
por: Williams, Adeline E., et al.
Publicado: (2020)

Single-cell analysis and stochastic modelling unveil large cell-to-cell variability in influenza A virus infection
por: Heldt, Frank S., et al.
Publicado: (2015)

Glycosylated diphyllin as a broad-spectrum antiviral agent against Zika virus
por: Martinez-Lopez, Alicia, et al.
Publicado: (2019)

Antiviral effects of natural small molecules on aquatic rhabdovirus by interfering with early viral replication
por: Zhou, Yan, et al.
Publicado: (2022)

Production of retroviral vectors in continuous high cell density culture
por: Hein, Marc D., et al.
Publicado: (2023)

Broad Antiviral Activity of Ginkgolic Acid against Chikungunya, Mayaro, Una, and Zika Viruses
por: Campos, Dalkiria, et al.
Publicado: (2020)

The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication
por: Sacramento, Carolina Q., et al.
Publicado: (2017)

A system for production of defective interfering particles in the absence of infectious influenza A virus
por: Bdeir, Najat, et al.
Publicado: (2019)

Corrigendum: The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication
por: Sacramento, Carolina Q., et al.
Publicado: (2017)

Interfering antiviral immunity: application, subversion, hope?
por: Manjunath, N., et al.
Publicado: (2006)

Design of Small Interfering RNAs for Antiviral Applications
por: Rothe, Diana, et al.
Publicado: (2010)

Bithiazole Inhibitors of Phosphatidylinositol 4‐Kinase (PI4KIIIβ) as Broad‐Spectrum Antivirals Blocking the Replication of SARS‐CoV‐2, Zika Virus, and Human Rhinoviruses
por: Grazia Martina, Maria, et al.
Publicado: (2021)

Continuous Influenza Virus Production in Cell Culture Shows a Periodic Accumulation of Defective Interfering Particles
por: Frensing, Timo, et al.
Publicado: (2013)

Natural products as Zika antivirals
por: Fong, Yuhui Deborah, et al.
Publicado: (2022)

4′-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication
por: Sourimant, Julien, et al.
Publicado: (2021)

Duck TRIM35 Promotes Tembusu Virus Replication by Interfering with RIG-I-Mediated Antiviral Signaling in Duck Embryo Fibroblasts
por: Zhou, Peng, et al.
Publicado: (2022)

Broadly Active Antiviral Compounds Disturb Zika Virus Progeny Release Rescuing Virus-Induced Toxicity in Brain Organoids
por: Pettke, Aleksandra, et al.
Publicado: (2020)

Broad-Spectrum Antivirals and Antiviral Drug Combinations
por: Oksenych, Valentyn, et al.
Publicado: (2022)

Small Interfering RNA Inhibition of Andes Virus Replication
por: Chiang, Cheng-Feng, et al.
Publicado: (2014)

Inhibition of Junín virus replication by small interfering RNAs
por: Artuso, María C., et al.
Publicado: (2009)

The Antiviral and Antitumor Effects of Defective Interfering Particles/Genomes and Their Mechanisms
por: Yang, Yicheng, et al.
Publicado: (2019)

Site-specific N-glycosylation analysis of animal cell culture-derived Zika virus proteins
por: Pralow, Alexander, et al.
Publicado: (2021)

RAGE inhibits human respiratory syncytial virus syncytium formation by interfering with F-protein function
por: Tian, Jane, et al.
Publicado: (2013)

Production of Defective Interfering Particles of Influenza A Virus in Parallel Continuous Cultures at Two Residence Times—Insights From qPCR Measurements and Viral Dynamics Modeling
por: Tapia, Felipe, et al.
Publicado: (2019)

Broad-Spectrum Antiviral Therapeutics
por: Rider, Todd H., et al.
Publicado: (2011)

Broad-spectrum antiviral agents
por: Zhu, Jun-Da, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_u3mf4u8ovrk14qq2itn2fju8jg